Literature DB >> 7205300

Reversible supranuclear ophthalmoplegia associated with Parkinsonism.

R J Guiloff, R J George, C D Marsden.   

Abstract

Two patients presented with a supranuclear ophthalmoplegia and clinical features otherwise indistinguishable from classical Parkinson's disease. Both had intercurrent infection, and recovery from the ophthalmoplegia paralleled that from the infection, but the Parkinsonian features improved more gradually on increasing doses of levodopa.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7205300      PMCID: PMC490600          DOI: 10.1136/jnnp.43.6.552

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  L-dopa in progressive supranuclear palsy.

Authors:  I Dehaene; M Bogaerts
Journal:  Lancet       Date:  1970-08-29       Impact factor: 79.321

2.  L-dopa for progressive supranuclear palsy.

Authors:  A Wagshul; R B Daroff
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

3.  L-dopa for progressive supranuclear palsy.

Authors:  R Jenkins
Journal:  Lancet       Date:  1969-10-04       Impact factor: 79.321

4.  L-dopa for progressive supranuclear palsy.

Authors:  M Gross
Journal:  Lancet       Date:  1969-12-20       Impact factor: 79.321

5.  L-dopa for progressive supranuclear palsy.

Authors:  H L Klawans
Journal:  Lancet       Date:  1969-12-20       Impact factor: 79.321

6.  L-dopa for progressive supranuclear palsy.

Authors:  E De Renzi; L A Vignolo
Journal:  Lancet       Date:  1969-12-20       Impact factor: 79.321

7.  L-dopa for progressive suparanulcear palsy.

Authors:  O W Sacks
Journal:  Lancet       Date:  1969-09-13       Impact factor: 79.321

8.  Oculomotor function in patients with Parkinson's disease.

Authors:  M S Corin; T S Elizan; M B Bender
Journal:  J Neurol Sci       Date:  1972-03       Impact factor: 3.181

9.  Progressive supranuclear palsy. Clinico-pathological study of four cases.

Authors:  S Behrman; J D Carroll; I Janota; W B Matthews
Journal:  Brain       Date:  1969       Impact factor: 13.501

10.  Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome). A report of 9 cases with particular reference to the mechanism of the oculomotor disorder.

Authors:  M R Dix; M J Harrison; P D Lewis
Journal:  J Neurol Sci       Date:  1971-07       Impact factor: 3.181

View more
  3 in total

1.  Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.

Authors:  N L Foster; S Gilman; S Berent; A A Sima; C D'Amato; R A Koeppe; S P Hicks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  Diffuse Lewy body disease presenting with a supranuclear gaze palsy.

Authors:  J M Fearnley; T Revesz; D J Brooks; R S Frackowiak; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

3.  Computed tomographic findings in progressive supranuclear palsy.

Authors:  H Saitoh; F Yoshii; Y Shinohara
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.